ISG15 and cancer: Results from 2 previously published EAC-related bulk RNA-Seq cohorts demonstrate that both ISG15 and markers for IFN response are increased in EAC, relative to normal esophagus or NDBE from patients with EAC, suggesting that higher ISG15 levels in cancer tissue may be a result of fortified IFN signaling from local T cell population(s).